Skip to Content
Merck
All Photos(3)

Key Documents

252700

Sigma-Aldrich

4-(Chlorosulfonyl)benzoic acid

96%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
ClSO2C6H4CO2H
CAS Number:
Molecular Weight:
220.63
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Assay

96%

form

solid

mp

233-235 °C (lit.)

functional group

carboxylic acid

SMILES string

OC(=O)c1ccc(cc1)S(Cl)(=O)=O

InChI

1S/C7H5ClO4S/c8-13(11,12)6-3-1-5(2-4-6)7(9)10/h1-4H,(H,9,10)

InChI key

PTCSSXYPZOFISK-UHFFFAOYSA-N

Application

4-(Chlorosulfonyl)benzoic acid was used in the preparation of polymer bound transfer hydrogenation catalyst and 4-(carboxymethyl-sulfamoyl)-benzoyladenosine. It was also used as a reagent in the sulfonation of γ-cyclodextrin.

Pictograms

Corrosion

Signal Word

Danger

Hazard Statements

Hazard Classifications

Skin Corr. 1B

Storage Class Code

8A - Combustible corrosive hazardous materials

WGK

WGK 3

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Mono-6-(O-2, 4, 6-triisopropylbenzenesulfonyl)-?-cyclodextrin, a novel intermediate for the synthesis of mono-functionalised ?-cyclodextrins.
Palin R, et al.
Tetrahedron Letters, 42(50), 8897-8899 (2001)
Synthesis and evaluation of a chiral heterogeneous transfer hydrogenation catalyst.
Bayston DJ, et al.
Tetrahedron Asymmetry, 9(12), 2015-2018 (1998)
Nguyen-Hai Nam et al.
Bioorganic & medicinal chemistry, 12(22), 5753-5766 (2004-10-23)
A number of Src SH2 domain inhibitors enhance the kinase catalytic activity by switching the closed inactive to the open active conformation. ATP-phosphopeptide conjugates were designed and synthesized as Src tyrosine kinase inhibitors based on a tetrapeptide sequence pTyr-Glu-Glu-Ile (pYEEI)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service